Author:
Lee Sang Min, ,Lee Won Sik,Shin Ho Jin,Lee Je-Jung,Sohn Sang Kyun,Moon Joon Ho,Eom Hyeon Seok,Won Jong Ho,Lee Kyoo-Hyung,Lee Je-Hwan,Kim Dae-Young,Yoon Sung-Soo,Kim Inho,Jung Chul Won,Kim Seok Jin,Kim Hawk,Lee Jae Hoon,Ryoo Hun-Mo,Lee Gyeong-Won,Kim Sung-Hyun,Mun Yeung-Chul,Kim Min Kyoung,Joo Young Don
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference20 articles.
1. Gokbuget N, Hoelzer D (2006) Treatment of adult acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 133–141
2. Fielding AK (2008) The treatment of adults with acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program. doi: 10.1182/asheducation-2008.1.381
3. Gottlieb AJ, Weinberg V, Ellison RR, Henderson ES, Terebelo H, Rafla S, Cuttner J, Silver RT, Carey RW, Levy RN (1984) Efficacy of daunorubicin in the therapy of adult acute lymphocytic leukemia: a prospective randomized trial by cancer and leukemia group B. Blood 64(1):267–274
4. Todeschini G, Meneghini V, Pizzolo G, Cassibba V, Ambrosetti A, Veneri D, Nadali G, Zanotti R, Tecchio C, Perona G (1994) Relationship between daunorubicin dosage delivered during induction therapy and outcome in adult acute lymphoblastic leukemia. Leukemia 8(3):376–381
5. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukaemias. French–American–British (FAB) co-operative group. Br J Haematol 33(4):451–458